Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -85.8% | -121.0% | 0 / 3 | -49.8% | +7.13 pp | -4.87 pp | +1.8% | 0.41 | 62.28 | 5,9 | −49,8% | 0,3 | −74,4% | 62.28 | 8.67 | +618,4% |
| Pts | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 6.000 (close price on 2026-10-14)EPS (TTM): 96,3
Financial charts
1.Revenue & growth
VND bn5,93Q2/26
1.Revenue & growth
VND bn5,93Q2/26
2.Profit & growth
VND bn0,14Q2/26
3.Profit mix (Penman)
VND bn1,10Q2/26
4.Margins & cost structure
%32.4%Q2/26
5.Returns & cash cycle
% · days-0.4%Q2/26
Outlier warning: 2 period(s) outside -1.825…1.825 days, drawn at the limit
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn83,6Q2/26
8.Funding & debt health
VND bn · times83,6Q2/26
9.Revenue backlog
VND bn0,24Q2/26
10.Valuation
times · %62,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %15Q2/26
Adjusted EPS growth, latest quarter
-85.8%
Average adjusted EPS growth, 3 quarters
-121%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26